DGX Quest Diagnostics Inc

  1. Stocks
  2. Healthcare
  3. NYSE: DGX

Price (delayed)

$227.86

Market cap

$25.15B

P/E Ratio

23.88

Dividend/share

$3.32

EPS

$9.54

Enterprise value

$30.91B

?
Relative Growth: Rel. Growth: 63
Relative Strength: Rel. Strength: 76
Relative Valuation: Rel. Valuation: 62
Relative Profitability: Rel. Profitability: 68

Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals ...

Highlights
Quest Diagnostics's quick ratio has increased by 49% YoY and by 41% QoQ
DGX's EPS is up by 13% year-on-year and by 4% since the previous quarter
DGX's price to earnings (P/E) is 36% higher than its 5-year quarterly average of 17.5 and 12% higher than its last 4 quarters average of 21.3
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.questdiagnostics.com/
Peers: LH NEO QGEN

Key stats

What are the main financial stats of DGX

DGX stock price

How has the Quest Diagnostics stock price performed over time
Intraday
-0.02%
1 week
8.15%
1 month
12.19%
1 year
32.55%
YTD
31.31%
QTD
7.51%

Financial performance

How have Quest Diagnostics's revenue and profit performed over time
Revenue
$11.56B
Gross profit
$3.83B
Operating income
$1.63B
Net income
$1.06B
Gross margin
33.1%
Net margin
9.2%
The net income has grown by 12% YoY and by 3.7% from the previous quarter
DGX's operating income is up by 11% year-on-year
The revenue has grown by 10% YoY and by 2.5% from the previous quarter
The gross profit has increased by 10% YoY and by 2.2% from the previous quarter

Price vs fundamentals

How does DGX's price correlate with its fundamentals

Growth

What is Quest Diagnostics's growth rate over time

Valuation

What is Quest Diagnostics stock price valuation
DGX P/E details
P/E
23.88
P/B
3.36
P/S
2.19
EV/EBIT
18.87
EV/EBITDA
13.93
EV/Sales
2.67
DGX's price to earnings (P/E) is 36% higher than its 5-year quarterly average of 17.5 and 12% higher than its last 4 quarters average of 21.3
DGX's EPS is up by 13% year-on-year and by 4% since the previous quarter
The stock's price to book (P/B) is 29% more than its 5-year quarterly average of 2.6 and 16% more than its last 4 quarters average of 2.9
Quest Diagnostics's equity has increased by 4% YoY and by 2% from the previous quarter
The stock's price to sales (P/S) is 29% more than its 5-year quarterly average of 1.7 and 15% more than its last 4 quarters average of 1.9
The revenue has grown by 10% YoY and by 2.5% from the previous quarter

Efficiency

How efficient is Quest Diagnostics business performance
Quest Diagnostics's return on invested capital has increased by 12% YoY
DGX's return on assets is up by 8% year-on-year
DGX's ROE is up by 6% year-on-year and by 2.8% since the previous quarter

Dividends

What is DGX's dividend history
Dividend details
DPS
$3.32
Dividend yield
1.46%
Payout ratio
34.8%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Quest Diagnostics financials performed over time
The total assets is 86% greater than the total liabilities
Quest Diagnostics's quick ratio has increased by 49% YoY and by 41% QoQ
The current ratio has increased by 46% YoY and by 35% QoQ
Quest Diagnostics's debt is 15% lower than its equity
Quest Diagnostics's equity has increased by 4% YoY and by 2% from the previous quarter
The company's debt to equity fell by 3.4% YoY and by 2.3% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.